Inventor · disambiguated record
Marie-Pierre De Bethune
Also filed as: DE BETHUNE MARIE-PIERRE · DE BETHUNE MARIE-PIERRE T M · DE BETHUNE MARIE-PIERRE T M M · DE BETHUNE MARIE-PIERRE T M M G
15 granted patents·7 pending applications·74 citations·filing 1997–2020
90Inventor score
Top patents by PatentIndex Score
22 records- 0181US7217506B2Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistanceTIBOTEC PHARM LTD·Filed 2003·Granted May 15, 2007·9 cites·4 claims
- 0278US6528251B2Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 2000·Granted Mar 4, 2003·13 cites·12 claims
- 0371US7935710B2Microbicidal pyrimidine or triazine for preventing sexual HIV transmissionTIBOTEC PHARM LTD·Filed 2003·Granted May 3, 2011·8 cites·19 claims
- 0471US7244752B2Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitorsTIBOTEC PHARM LTD·Filed 2002·Granted Jul 17, 2007·5 cites·25 claims
- 0570US7863306B2Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitorsTIBOTEC PHARM LTD·Filed 2009·Granted Jan 4, 2011·0 cites·1 claims
- 0668US6221578B1Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 1997·Granted Apr 24, 2001·28 cites·24 claims
- 0766US7473524B2Mutational profiles in HIV-1 protease correlated with phenotypic drug resistanceAZIJN HILDE·Filed 2003·Granted Jan 6, 2009·8 cites·2 claims
- 0863US2020345733A1Microbicidal Pyrimidine or Triazine Containing CompoundsJANSSEN SCIENCES IRELAND UC·Filed 2020·Application pending·0 cites
- 0960US7659404B2Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitorsTIBOTEC PHARM LTD·Filed 2002·Granted Feb 9, 2010·1 cites·2 claims
- 1058US8036861B2Method and means for determining the replication rate of a viral populationTIBOTEC PHARM LTD·Filed 2006·Granted Oct 11, 2011·2 cites·12 claims
- 1156US8592161B2Mutational profiles in HIV-1 protease correlated with phenotypic drug resistanceDE MEYER SANDRA·Filed 2006·Granted Nov 26, 2013·0 cites·5 claims
- 1254US7595334B2Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitorsTIBOTEC PHARM LTD·Filed 2007·Granted Sep 29, 2009·0 cites·17 claims
- 1353US8076062B2Mutational profiles in HIV-1 protease correlated with phenotypic drug resistanceAZIJN HILDE·Filed 2008·Granted Dec 13, 2011·0 cites·6 claims
- 1452US2005214744A1New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistanceAZJIN HILDE·Filed 2003·Application pending·0 cites
- 1550US2017100399A1Microbicidal Pyrimidine Or Triazine Containing CompoundsJANSSEN SCIENCES IRELAND UC·Filed 2016·Application pending·0 cites
- 1648US7622490B2Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitorsTIBOTEC PHARM LTD·Filed 2002·Granted Nov 24, 2009·0 cites·28 claims
- 1748US2011165093A1Microbicidal pyrimidine or triazine for preventing sexual hiv transmissionTIBOTEC PHARM LTD·Filed 2011·Application pending·0 cites
- 1848US2003152917A1Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 2003·Application pending·0 cites
- 1943US2010009341A1Methods and means for assessing hiv gag/protease inhibitor therapyDE BAERE INKY PAUL MADELEINE·Filed 2007·Application pending·0 cites
- 2041US2005158709A1Methods for determinging the influence of protein binding on antiretroviral activityFiled 2003·Application pending·0 cites
- 2139US8673551B2Methods, plasmid vectors and primers for assessing HIV viral fitnessRIMSKY LAURENCE TATIANA·Filed 2006·Granted Mar 18, 2014·0 cites·10 claims
- 2236US7429677B2Small molecule entry inhibitorsTIBOTEC PHARM LTD·Filed 2003·Granted Sep 30, 2008·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Marie-Pierre De Bethune files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →